End of the Road for Immune Checkpoint Inhibitors in Prostate Cancer?

MedPage Today) — Adding an immune checkpoint inhibitor (ICI) to chemotherapy for advanced prostate cancer failed to improve survival as compared with chemotherapy alone, according to final results from a large randomized trial.
Men with metastatic…